Effect of addition of Backward walking to traditional treatment on pain, balance, walking pattern, strength, flexibility, disability and mobility in patients with Knee pai
- Conditions
- Health Condition 1: M171- Unilateral primary osteoarthritisof knee
- Registration Number
- CTRI/2023/08/056593
- Lead Sponsor
- Jamia Millia Islamia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
a) Individuals fulfilling, clinical criteria listed by the American College of Rheumatology: knee pain and any three out of the following six criteria (age >50 years; morning stiffness lasting <30 min; crepitus on active motion; bony tenderness; bony enlargement; and no warmth on touch (Wu CW, et al. 2005).
b)Individuals on Grade 2 and 3 or mild to moderate as per Kellgren and Lawrence scale.
c)Individuals with knee pain for more than 6 weeks.
d)Age: above 40 (male and female).
e)Patient with body mass index less than 25 kg/m2
f)In case of bilateral involvement more severely involve knee will be considered.
g)Patients with pain less than 7 or equal to 3 or more on the Numerical Pain Rating Scale
Individuals will be excluded from the study if they will have.
a)Any underlying pathology, History of ankle disease, Congenital deformities, other systemic arthritis, recent surgeries, trauma, or fractures of the lower limb
b)Known cases of severe osteoporosis.
c)With any neurological disorder including balance issues and motor and sensory loss.
d)Taking intraarticular injection for knee pain for the last 6 months
e)Presence of acute joint effusion
f)Individuals having visual dysfunction or refractory errors are not corrected with glasses or contact lenses.
g)Individuals having baseline history of established coronary artery disease (CAD), typical angina or heart failure.
h)Patient with metal implant or cardiac pacemaker.
i)Patients with uncontrolled arterial hypertension, atrial fibrillation or flutter, hypertrophic and dilated cardiomyopathy, valvular heart disease, cerebrovascular disease (history of stroke, transient ischemic attacks, or carotid artery surgery), are contraindicated to the exercise test were not included in the study. (American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription (8th edition).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method a)Pain intensity on the NPRS scale, <br/ ><br>b)Kinematic parameters of Gait( including Stride length, Step length, Stride time, Step time, Gait velocity & Cadence) using kinovea software <br/ ><br>c)Balance parameters ( including COP sway, COP range, Proprioception, Reaction time, & Multidimensional stability) using pedalosensa move <br/ ><br>d)Muscle strength ( hip flexor to hip extensor strength ratio & quadriceps to hamstring strength ratio ) using Lafayette dynamometerTimepoint: week 0 , after 3rd week & after completion of 6th week
- Secondary Outcome Measures
Name Time Method a)Functional disability score using KOOS scale, <br/ ><br>b)Functional mobility using Time up & go test, & muscle c) muscle flexibility <br/ ><br>Timepoint: week 0 , after 3rd week & after completion of 6th week